Search Results
You are looking at 1 - 4 of 4 items for
- Author: H. Nagase x
- Refine by access: All content x
Search for other papers by A. Hanada in
Google Scholar
PubMed
Search for other papers by H. Nagase in
Google Scholar
PubMed
Summary. Semen was diluted 1:9 with egg yolk–citrate medium containing 0·31– 3·1 m (final concentration) formamide, butyramide, acetamide, propionamide, dimethylformamide, lactamide, malomide, ethylene glycol, trimethylene glycol, dimethylsulphoxide (DMSO) or glycerol. After 30 min incubation at 20°C, sperm motility was superior in hypertonic solutions of acetamide, lactamide, dimethylsulphoxide, trimethylene glycol and ethylene glycol. Some of these compounds were added to semen diluted 1:2 in an isotonic egg-yolk–glucose– lactose–raffinose solution and frozen by the pellet method. Relatively good survival of motility was obtained in 1·0 m-DMSO, -lactamide or -acetamide. Dimethylformamide (0·5 m), ethylene glycol (0·5–1·5M), trimethylene glycol (1·5 m) and propionamide (0·75 m) also gave some protection. Insemination of does with semen frozen and thawed with 1·0 m-DMSO, -lactamide or -acetamide gave fertilization rates of 68–88%, and 84% (38/45) of does gave birth to an average of 5·3 young.
Search for other papers by L. A. Salamonsen in
Google Scholar
PubMed
Search for other papers by A. L. Hampton in
Google Scholar
PubMed
Search for other papers by R. Suzuki in
Google Scholar
PubMed
Search for other papers by H. Nagase in
Google Scholar
PubMed
Ovine trophoblast interferon modulates the secretion of a number of proteins by ovine endometrium, but only one of these proteins has so far been identified. We examined the effects of trophoblast interferon on the secretion of matrix metalloproteinase-1, -2 and -3 by cultured ovine endometrial cells and determined whether they are mediated via effects on prostaglandin synthesis. Both ovine trophoblast interferon (30 ng ml−1) and human recombinant interferon α (50 U ml−1) inhibited the production of latent matrix metalloproteinase-1 and -3 (P< 0.05), as measured by enzyme assays, but had no effect on the secretion of latent matrix metalloproteinase-2. These inhibitory effects were not overcome by PGE2 or PGF2α (each 10 μmol l−1) either alone or in combination. Indomethacin (12 μmol l−1) similarly inhibited the production of latent matrix metalloproteinase-1 and -3, but production was partially restored by adding the prostaglandins either singly or in combination. PGE2 and PGF2α together had no effect on enzyme production. These data were confirmed by gelatin and casein zymography. Northern analysis showed a 4.5-fold increase in the abundance of specific mRNA for latent matrix metalloproteinase-1 following treatment of cells with phorbol myristate acetate, but a marked decrease following interferon treatment. Thus, ovine trophoblast interferon inhibits the production of the latent forms of matrix metalloproteinase-1 and -3 by ovine endometrial cells, and this is independent of its effect on prostaglandin production.
Search for other papers by L. A. Salamonsen in
Google Scholar
PubMed
Search for other papers by H. Nagase in
Google Scholar
PubMed
Search for other papers by R. Suzuki in
Google Scholar
PubMed
Search for other papers by D. E. Woolley in
Google Scholar
PubMed
Ovine endometrial cells (epithelial plus stromal), prepared from ovariectomized ewes treated with oestrogen and progesterone to mimic the luteal phase of the oestrous cycle were maintained in serum-free medium for 48 h in the presence or absence of phorbol myristate acetate (PMA, 100 nmol l−1), a known stimulus for production of matrix metalloproteinases (MMP) in other cells. Matrix metalloproteinase-1 (MMP-1, interstitial collagenase) and matrix metalloproteinase-2 (MMP-2, gelatinase A) activities were expressed by the cells in the absence of PMA; most were in the latent form and required activation by (4-aminophenyl) mercuric acetate (APMA). Exposure to PMA over 48 h resulted in a significant increase in MMP-1 activity but only a modest and nonsignificant increase in MMP-2 activity. Gelatin zymography demonstrated that proMMP-2 (72 kDa) was produced by both PMA-treated and untreated cells and an active form of 67 kDa was also present. Immunolocalization of MMP-1 and MMP-2 was seen within the cells following treatment with monensin. Highly purified epithelial and stromal cells were similarly cultured and analysis of the conditioned medium showed that MMP-1 and MMP-2 were produced predominantly by stromal rather than epithelial cells. Thus, both MMP-1, which degrades interstitial collagens, and MMP-2, an important enzyme for degradation of type IV and V collagens, are synthesized and released by ovine endometrial stromal cells in culture, but MMP-1 is produced primarily upon stimulation, whereas MMP-2 production is constitutive. It is postulated that these enzymes have important roles in endometrial remodelling and implantation.
Search for other papers by M. Jeziorska in
Google Scholar
PubMed
Search for other papers by H. Nagase in
Google Scholar
PubMed
Search for other papers by L. A. Salamonsen in
Google Scholar
PubMed
Search for other papers by D. E. Woolley in
Google Scholar
PubMed
Immunolocalization techniques were used to examine the distribution of the matrix metalloproteinases gelatinase B and stromelysin 1 in human endometrial specimens, taken across the normal menstrual cycle. Gelatinase B was produced by glandular epithelial cells for approximately 7 days during the proliferative phase, with polymorphonuclear leucocytes, macrophages and eosinophils providing most of this enzyme at menstruation. There was no evidence that gelatinase B is produced by stromal cells or mast cells during the cycle. Immunoreactive gelatinase B in glandular epithelial cells was greatest during the late proliferative phase and just after ovulation; its presence in glandular secretion and the uterine fluid was optimal during the peri-implantation phase. Gelatinase B was clearly associated with an influx of polymorphonuclear leucocytes, macrophages and eosinophils just before, and during, menstruation. In contrast, immunostaining for stromelysin 1 was much weaker than that for gelatinase B, and was present only around stromal cells and limited to microfocal locations at times coincident with stromal oedema (days 8–10 and 21–22). Both enzymes were widely distributed in specimens just before and during menstruation, and were particularly prominent in connective tissue stroma and vascular basement membranes. Specimens at the early proliferative stage were devoid of both enzymes. The data provide further evidence supporting a role for metalloproteinases in endometrial biology, not only in matrix remodelling during the cycle, but also in glandular secretions potentially relevant to blastocyst recognition and implantation. Our observations emphasize the functional importance of specific cell types and the temporal regulation of gelatinase B and stromelysin 1 throughout the normal menstrual cycle.
